Form 8-K - Current report:
SEC Accession No. 0001104659-21-040030
Filing Date
2021-03-23
Accepted
2021-03-23 08:10:46
Documents
1
Period of Report
2021-03-23
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm219778d3_8k.htm 8-K 21136
  Complete submission text file 0001104659-21-040030.txt   22187
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38944 | Film No.: 21763206
SIC: 2834 Pharmaceutical Preparations